Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1994 4
1996 2
1999 1
2002 3
2003 1
2005 1
2006 2
2007 1
2008 3
2009 9
2010 1
2011 1
2013 4
2014 7
2015 15
2016 17
2017 13
2018 16
2019 12
2020 21
2021 14
2022 18
2023 6
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Results by year
Filters applied: . Clear all
Page 1
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma.
Alderuccio JP, Arcaini L, Watkins MP, Beaven AW, Shouse G, Epperla N, Spina M, Stefanovic A, Sandoval-Sus J, Torka P, Alpert AB, Olszewski AJ, Kim SH, Hess B, Gaballa S, Ayyappan S, Castillo JJ, Argnani L, Voorhees TJ, Saba R, Chowdhury SM, Vargas F, Reis IM, Kwon D, Alexander JS, Zhao W, Edwards D, Martin P, Cencini E, Kamdar M, Link BK, Logothetis CN, Herrera AF, Friedberg JW, Kahl BS, Luminari S, Zinzani PL, Lossos IS. Alderuccio JP, et al. Among authors: chowdhury sm. Blood Adv. 2022 Apr 12;6(7):2035-2044. doi: 10.1182/bloodadvances.2021006844. Blood Adv. 2022. PMID: 35196377 Free PMC article.
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study.
Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan C, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N, Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G. Epperla N, et al. Among authors: chowdhury sm. J Hematol Oncol. 2022 Jul 16;15(1):96. doi: 10.1186/s13045-022-01316-1. J Hematol Oncol. 2022. PMID: 35842643 Free PMC article.
Graphene-based platforms for cancer therapeutics.
Patel SC, Lee S, Lalwani G, Suhrland C, Chowdhury SM, Sitharaman B. Patel SC, et al. Among authors: chowdhury sm. Ther Deliv. 2016;7(2):101-16. doi: 10.4155/tde.15.93. Epub 2016 Jan 15. Ther Deliv. 2016. PMID: 26769305 Free PMC article. Review.
Proteomics Network Analysis of Polarized Macrophages.
Chakrabarty JK, Kamal AHM, Shahinuzzaman ADA, Chowdhury SM. Chakrabarty JK, et al. Among authors: chowdhury sm. Methods Mol Biol. 2020;2184:61-75. doi: 10.1007/978-1-0716-0802-9_5. Methods Mol Biol. 2020. PMID: 32808218
Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas.
George B, Chowdhury SM, Hart A, Sircar A, Singh SK, Nath UK, Mamgain M, Singhal NK, Sehgal L, Jain N. George B, et al. Among authors: chowdhury sm. Cancers (Basel). 2020 May 22;12(5):1328. doi: 10.3390/cancers12051328. Cancers (Basel). 2020. PMID: 32455989 Free PMC article. Review.
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2.
Chowdhury SM, Talukder SA, Khan AM, Afrin N, Ali MA, Islam R, Parves R, Al Mamun A, Sufian MA, Hossain MN, Hossain MA, Halim MA. Chowdhury SM, et al. J Phys Chem B. 2020 Nov 5;124(44):9785-9792. doi: 10.1021/acs.jpcb.0c05621. Epub 2020 Oct 23. J Phys Chem B. 2020. PMID: 33095007 Free PMC article.
145 results